|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 7.550 USD | -8.82% |
|
-.--% | +0.67% |
| 07-10 | Redcare extends losses, Metzler tempers competition concerns | DP |
| 07-07 | REDCARE PHARMACY : Jefferies keeps its Buy rating | ZD |
Evolution of the Average Target: Redcare Pharmacy NV
Evolution of the Target Price: Redcare Pharmacy NV
Changes in Analyst Recommendations: Redcare Pharmacy NV
| Consensus | Analysts' recommendations evolution (4 months) | Financial estimates divergence | Analysts' Target price divergence | Objective/dr gap | ||
|---|---|---|---|---|---|---|
 | +90.2% | |||||
| +54.43% | |||||
| +22.92% | |||||
| +65.17% | |||||
| +50.44% | |||||
| +36.97% | |||||
| +38.74% | |||||
| +14.75% | |||||
| - | - | +216.05% | |||
| Average | +65.52% | |||||
| Weighted average by Cap. | +66.85% |
Analysts' Consensus
Analyst Consensus Detail
Consensus revision (last 18 months)
Analysts covering the company
| JEFFERIES | Martin Comtesse |
| BERENBERG | Gerhard Orgonas |
| BAADER BANK | Volker Bosse |
| BARCLAYS | Guillaume Galland |
| UBS | Olivier Calvet |
| DEUTSCHE BANK RESEARCH | Jan Koch |
| ODDO BHF | |
| Kepler Cheuvreux | |
| HAUCK AUFHÄUSER INVESTMENT BANKING | Christian Salis |
| WARBURG RESEARCH | Michael Heider |
| MORGAN STANLEY | Robert Davies |
| CREDIT SUISSE | Olivier Calvet |
| BANK OF AMERICA (BOFA) | Maria-Laura Adurno |
| HAUCK AUFHÄUSER LAMPE | Christian Salis |
| HAUCK & AUFHÄUSER | Christian Salis |
| DEUTSCHE BANK | Uwe Schupp |
| CITIGROUP | Natasha Brilliant |
| MAINFIRST | Daniel Grigat |
| COMMERZBANK | Andreas Riemann |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- RDC Stock
- SAEYY Stock
- Consensus Redcare Pharmacy NV
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
